---
title: "Eli Lilly, Dell Among Stocks To Watch As Market Leadership Shifts"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293823751.md"
description: "Investors are shifting away from AI-related stocks as they weaken, turning towards sectors like energy and health care instead. Companies like Eli Lilly and Dell are gaining attention as potential stocks to watch amidst this market leadership shift."
datetime: "2026-07-25T13:19:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293823751.md)
  - [en](https://longbridge.com/en/news/293823751.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293823751.md)
---

# Eli Lilly, Dell Among Stocks To Watch As Market Leadership Shifts

Investors are shifting away from AI-related stocks as they weaken, turning towards sectors like energy and health care instead. Companies like Eli Lilly and Dell are gaining attention as potential stocks to watch amidst this market leadership shift.

### Related Stocks

- [DELL.US](https://longbridge.com/en/quote/DELL.US.md)
- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)
- [LLYX.US](https://longbridge.com/en/quote/LLYX.US.md)
- [DLLL.US](https://longbridge.com/en/quote/DLLL.US.md)
- [ELIS.US](https://longbridge.com/en/quote/ELIS.US.md)
- [LLYZ.US](https://longbridge.com/en/quote/LLYZ.US.md)
- [ELIL.US](https://longbridge.com/en/quote/ELIL.US.md)

## Related News & Research

- [Lilly Targets Early 2027 Filing for Next Obesity Drug](https://longbridge.com/en/news/293649982.md)
- [HBM Healthcare swings to CHF 238 million Q1 FY27 profit; NAV per share rises 13%](https://longbridge.com/en/news/293701781.md)
- [Eli Lilly's Retatrutide Meets Primary Endpoint In Phase 3 TRIUMPH-2 And TRIUMPH-3 Trials](https://longbridge.com/en/news/293605576.md)
- [Lilly announces more next-gen obesity drug data, plans Q1 2027 FDA application](https://longbridge.com/en/news/293600518.md)
- [Eli Lilly says it will file for approval of next-generation obesity drug in 2027 as it clears two more trials](https://longbridge.com/en/news/293607076.md)